3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Pancreatic Neoplasms
18
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
6
Triple Negative Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neoplasm Metastasis
5
Stomach Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Pancreatic Adenocarcinoma
2
Lung Neoplasms
2
Inflammatory Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Solid Cancer
1
Sarcoma
1
Oropharyngeal Neoplasms
1
Non-Small Cell Lung Cancer Metastatic
1
Non Small Cell Lung Cancer NSCLC
1
Neoplasms
1
Mouth Neoplasms
1
Lymphoma, Non-Hodgkin
1
Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy
1
Lip Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Invasive Breast Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Interventions
Temozolomide
41
Radiotherapy
19
Radiation
12
Nivolumab
10
pembrolizumab
8
Magnetic Resonance Spectroscopy
8
Bevacizumab
7
Specimen Handling
6
poly ICLC
4
atezolizumab
4
Lomustine
4
Ipilimumab
4
Surgical Procedures, Operative
3
Photons
3
Immunoglobulin G
3
Disulfides
3
Cyclophosphamide
3
veliparib
2
sargramostim
2
rocakinogene sifuplasmid
2
olaparib
2
niraparib
2
Transurethral Resection of Bladder
2
Surveys and Questionnaires
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Radiosurgery
2
OKN 007
2
Mycophenolic Acid
2
Metformin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Glioblastoma
×
Albumin-Bound Paclitaxel
×
Clear all
NCT04528680
2026-04-13
SC9/ABX
Northwestern University
Phase 1/2
Active not recruiting
57 enrolled